glp 1 approved for heart disease GLP-1 medications are not just weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major of the evidence supporting the

Liraglutide, the most extensively studied drug, consistently reduced both amyloidbeta and tau pathology

The large molecules in these drugs arent easily absorbed in the gut, so have to go directly into the body by needle

It remains unknown whether semaglutide causes medullary thyroid carcinoma in humans

Although there is no data in humans, GLP-1RAs should not be used in patients with a past or family history of medullary thyroid cancer or in patients with multiple endocrine neoplasia type 2

Range of weight loss over 12 weeks can be 3% to 15%. In her experience, 15% often corresponds to about 33 pounds (15 kilograms)